Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)

Study question What is the long term efficacy of betahistine dihydrochloride on the incidence of vertigo attacks in patients with Meniere’s disease, compared with placebo? Methods The BEMED trial is a multicentre, double blind, randomised, placebo controlled, three arm, parallel group, phase III, do...

Descripción completa

Detalles Bibliográficos
Autores principales: Adrion, Christine, Fischer, Carolin Simone, Wagner, Judith, Gürkov, Robert, Mansmann, Ulrich, Strupp, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721211/
https://www.ncbi.nlm.nih.gov/pubmed/26797774
http://dx.doi.org/10.1136/bmj.h6816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721211/
https://www.ncbi.nlm.nih.gov/pubmed/26797774
http://dx.doi.org/10.1136/bmj.h6816

Ejemplares similares